Medical News

RSS

PrimeraDx receives its fourth patent

PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has received its fourth patent. The patent, entitled “Methods and systems for dynamic gene expression profiling”, with inventor Vladimir Slepnev, Ph.D., describes a novel method of quantitative analysis of gene expression allowing simultaneous interrogation of multiple genes in a single tube reaction.

5 Oct 2009

Majority of Americans believe they are well-protected from H1N1

A new Harris poll, commissioned by SCA Tissue North America’s Tork® brand, reveals that 74 percent of U.S. adults say it is unlikely they will contract H1N1 this year.

5 Oct 2009

Preclinical study results of AVL-181 protease inhibitor presented

Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.

5 Oct 2009

FDA grants Impax tentative approval of ANDA for FLOMAX generic version

Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company’s Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.

5 Oct 2009

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

Peregrine Pharmaceuticals, Inc. today reported additional positive results in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC). Data previously reported from the initial cohort of 21 patients in the study had indicated that 11 of 17 evaluable patients with locally advanced or metastatic NSCLC achieved an objective tumor response according to RECIST criteria.

5 Oct 2009

ABC of fitness etiquette

Whether you are a gym expert or a fitness center novice, you've probably seen your share of interesting and sometimes amusing etiquette faux pas: the grunter, the space invader, the cell phone talker and the, ehem, "fragrant neighbor."

5 Oct 2009

New consumer At-Home Skin Typing and Analysis Kit unveiled

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.

5 Oct 2009

Novo Nordisk initiates its share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

From Novo Nordisk 5 Oct 2009

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.

5 Oct 2009

Discus Dental to host 2010 Las Vegas Extravaganza

Discus Dental®, LLC, innovators in dental and oral-hygiene products and the worldwide leader in professional teeth whitening products, today announced the company will be hosting its 2010 Las Vegas Extravaganza, featuring keynote speaker, former NBC news anchor Tom Brokaw.

5 Oct 2009

avVaa World Health Care Products launches Neuroskin Psoriasis Relief DRTV media test campaign

avVaa World Health Care Products Inc. a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the launch of its two week Neuroskin(R) Psoriasis Relief DRTV media test campaign.

5 Oct 2009

BronxRHIO to deploy Axolotl's health information exchange solutions

The Bronx Regional Health Information Organization today announced that it has signed an agreement with Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services. The BronxRHIO, a not-for-profit organization established by the borough’s leading healthcare organizations, will deploy Axolotl’s Elysium® Exchange suite of solutions to enable healthcare providers to securely access and share clinical information, with a goal of reducing healthcare costs and improving the quality of patient care.

5 Oct 2009

Millennium Administrators named to the Philadelphia 100 for helping employers to control healthcare costs

Millennium Administrators, a healthcare consulting firm specializing in administering employee healthcare benefits, has been recognized as one of the fastest growing companies the Greater Philadelphia Region. Millennium was named to the Philadelphia 100 for the second time in the past three years.

5 Oct 2009

Baptist Healthcare System deploys Mckesson's Horizon Enterprise Revenue Management solution

Kentucky-based Baptist Healthcare System plans to stay ahead of the information technology curve. When a switch was flipped on Aug. 15 at Baptist Hospital Northeast in La Grange, Ky., the health system became the first to simultaneously implement both the access and business management modules of McKesson’s Horizon Enterprise Revenue Management™ solution.

5 Oct 2009

Prednisporin is a key asset in the proposed acquisition of Fovea by Sanofi-Aventis

CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.

5 Oct 2009

Coventry Health Care signs definitive agreement to acquire Preferred Health Systems

Coventry Health Care, Inc. (NYSE: CVH) announced today that it has signed a definitive agreement to acquire Preferred Health Systems, Inc. (“PHS”), a wholly-owned subsidiary of Via Christi Health System, Inc.

5 Oct 2009

QuadraMed announces the launch of its ICD-10 Countdown Program

QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.

5 Oct 2009

Biochemics signs research collaboration agreement with Unilever

BioChemics, Inc. a company “enhancing drug delivery through biophysical modulation,” is pleased to announce the signing of a research collaboration agreement with Unilever, one of the world’s largest consumer goods companies, to utilize BioChemics’ proprietary topical delivery technology for the delivery of Unilever’s compounds.

5 Oct 2009

Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations

Isilon® Systems (Nasdaq: ISLN), the proven leader in scale-out NAS, today announced that Pharmacogenomics Centre, a partnership between Genome Quebec and the Montreal Heart Institute focused on enhancing new and existing drug development research programs through the inclusion of genetic information, has deployed Isilon IQ to accelerate its next-generation genetic sequencing operations.

5 Oct 2009

SonoSite Mobile Solutions for cordless charging of ultrasound systems

SonoSite, Inc., the world leader and specialist in hand-carried and point-of-care ultrasound, announced today SonoSite® Mobile Solutions, for cordless charging and extended battery life of its ultrasound systems.

5 Oct 2009

Medical News

PrimeraDx receives its fourth patent

Majority of Americans believe they are well-protected from H1N1

Preclinical study results of AVL-181 protease inhibitor presented

FDA grants Impax tentative approval of ANDA for FLOMAX generic version

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

ABC of fitness etiquette

New consumer At-Home Skin Typing and Analysis Kit unveiled

Novo Nordisk initiates its share repurchase programme

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Discus Dental to host 2010 Las Vegas Extravaganza

avVaa World Health Care Products launches Neuroskin Psoriasis Relief DRTV media test campaign

BronxRHIO to deploy Axolotl's health information exchange solutions

Millennium Administrators named to the Philadelphia 100 for helping employers to control healthcare costs

Baptist Healthcare System deploys Mckesson's Horizon Enterprise Revenue Management solution

Prednisporin is a key asset in the proposed acquisition of Fovea by Sanofi-Aventis

Coventry Health Care signs definitive agreement to acquire Preferred Health Systems

QuadraMed announces the launch of its ICD-10 Countdown Program

Biochemics signs research collaboration agreement with Unilever

Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations

SonoSite Mobile Solutions for cordless charging of ultrasound systems

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News